ZOMETA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, France, Hong Kong, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ZOMETA contains one active pharmaceutical ingredient (API):

1 Zoledronic acid
UNII 6XC1PAD3KF - ZOLEDRONIC ACID

Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.

Read about Zoledronic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M05BA08 Zoledronic acid M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 6371H, 9653C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526514010078703
Country: CA Health Products and Food Branch Identifier(s): 02248296
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 03401343, 03401610, 07363042, 07363071, 08830480, 10392567, 10392573, 10782096, 10990883, 10992327, 10992356, 11003674, 11542891, 11554061, 12550527, 12896183, 13352657, 13515680, 13576598, 14216258, 14324120, 15257650, 16732923, 16732946
Country: EE Ravimiamet Identifier(s): 1060298, 1060300, 1060311, 1210228, 1210239, 1210240, 1538625, 1538636, 1538647
Country: FR Base de données publique des médicaments Identifier(s): 66716961
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 195699, 73332
Country: HK Department of Health Drug Office Identifier(s): 51819, 63017, 65975, 66742
Country: JP 医薬品医療機器総合機構 Identifier(s): 3999423A1044, 3999423A2024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1011297, 1031505, 1031506, 1031507, 1031508, 1031509, 1063131, 1063132, 1063133
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 559M2000
Country: NL Z-Index G-Standaard Identifier(s): 14956187
Country: NL Z-Index G-Standaard, PRK Identifier(s): 74888, 98795
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10890, 9596
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100104660, 100126063, 100309237
Country: SG Health Sciences Authority Identifier(s): 13050P, 14316P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504790559
Country: US FDA, National Drug Code Identifier(s): 0078-0387
Country: ZA Health Products Regulatory Authority Identifier(s): 38/34/0086

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.